We encourage companies
that project change
that project change
t
t@CaixaCR
- Our team members @amvall and @Roma_Jeli will be present at @SlushHQ to connect with fellow #VCs, #founders and… https://t.co/ONWDxSms8J
- Caixa Capital Risc led the sale of its portfolio company @SanifitLabs to @ViforPharma with a 205M€ upfront payment… https://t.co/8IprMIKyfp
- Next week we are hosting with the EIC a #deeptech startup pitching event with some of the most successful #deeptech… https://t.co/Kev8dkxYrc
N
News & events
Caixa Capital Risc leads sale of Sanifit Therapeutics to Vifor Pharma with upfront payment of €205M
24.11.2021
• Largest acquisition in history of Spanish biotechnology sector and largest operation to date for Caixa Capital Risc
• Holding 20% of the capital, Caixa Capital Risc is Sanifit’s biggest stakeholder and has supported company since 2006, participating in all financing rounds for a total investment of over €23M
Other news See all news »
-
Caixa Capital Risc acquires a stake in AlgaEnergy, leader in innovation in the microalgae sector
20.07.2021
• CriteriaCaixa's venture capital management company and the CDTI fund Innvierte EconomÃa Sostenible will have a minority stake in the company. • AlgaEnergy... -
Caixa Capital Risc strengthens its commitment to the cybersecurity business by acquiring a stake in start-up company Build38 and searches for success cases of emerging companies
19.01.2021
• Caixa Capital Risc co-leads, together with the German fund eCapital, an investment of 3 million euros in the cybersecurity startup, whose solution represents ... -
Medlumics raises €14M in a Series E financing co-led by Asabys Partners, VI Partners and CDTI Innvierte, together with existing investors Andera Partners, Caixa Capital Risc and Innogest
09.10.2020
• Medlumics develops a unique real-time, photonically guided radiofrequency (RF) irrigated ablation catheter to improve the treatment of Atrial Fibrillation â...